'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Dr. Rachel Danis won a research grant from AbbVie to study the pharmacodynamics of elagolix, a GnRH-antagonist drug used in reproductive medicine. That is an unusually specific credential for a fertility physician—and it captures how she practices: she treats patients in the clinic while staying close to the evidence behind the drugs and protocols she prescribes.
Her training path runs on two tracks. She studied at Barnard College of Columbia University, earned her medical degree at Drexel University College of Medicine, completed OB-GYN residency at Hahnemann University Hospital, and then trained in Reproductive Endocrinology and Infertility at the University of Southern California. At USC she also completed a Master of Science in Clinical, Biomedical, and Translational Investigation—the research degree that underpins her habit of grounding treatment decisions in primary literature.
Academic medicine has stayed central to her career. She conducts research, writes book chapters, and has been a devoted educator to medical students, residents, and junior fellows.
Clinical Expertise
- IVF and reproductive endocrinology: full-cycle management from stimulation through transfer, with individualized decisions informed by current evidence.
- Endometriosis-related infertility: attention to how endometriosis affects fertility and how medical and assisted-reproduction strategies combine.
- Endocrine and medication-supported care: her work on elagolix and GnRH-related drugs gives her a finer read on how medications behave inside a fertility plan.
- Clinical and translational research: connecting research questions to real clinical problems so evidence reaches the exam room.
Why Choose Dr. Danis
Danis’s clearest differentiator is that she is a reproductive specialist with formal research training, not just clinical credentials. The AbbVie grant on elagolix pharmacodynamics placed her directly on a frontier question in reproductive endocrinology.
Her work has appeared in Fertility and Sterility, Fertility & Sterility Reports, the Journal of Assisted Reproduction and Genetics, the Journal of Minimally Invasive Gynecology, and the Journal of Steroid Biochemistry and Molecular Biology, and she has presented at national conferences. For patients who care whether their doctor is keeping pace with the evidence, that publication record is a concrete signal.
She is also a committed teacher of medical students and residents—work that demands explaining the reasoning behind each step, and that shows up in how clearly she walks patients through their options.
Professional Affiliations
Danis is part of the Mount Sinai Medical System. Her clinical training spans Drexel University College of Medicine, OB-GYN residency at Hahnemann University Hospital, and Reproductive Endocrinology and Infertility fellowship at the University of Southern California, alongside a USC Master’s degree in clinical, biomedical, and translational investigation.
Suitable For
- Patients with endometriosis-related infertility: her research interest and pharmacology knowledge bear directly on the fertility challenges endometriosis creates.
- Patients who want evidence- and mechanism-based plans: the translational-research degree makes her inclined to explain every decision with data.
- Cases that combine endocrine and medication-supported care: a deeper grasp of how reproductive drugs work inside a cycle.
- Patients who value a teaching and research background: an option for those who want a physician active on both the clinical and academic sides.